Oxcarbazepine or Eslicarbazepine Metabolite (MHD)
Also known as: OXCARB
Use
Optimize drug therapy and monitor patient adherence.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Oxcarb or Eslicarb Metabolite (MHD)
Analyte
LOINC Codes
- 31019-3 - 10OH-Carbazepine SerPl-mCnc
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2 EDTA)
Collection Instructions
Timing of specimen collection: Pre‑dose (trough) draw - At steady state concentration. Separate serum or plasma from cells within 2 hours of collection.
Storage Instructions
Refrigerated.
Causes for Rejection
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | After separation from cells: Ambient: 6 weeks |
| Refrigerated | 6 weeks |
| Frozen | 3 months (avoid repeated freeze/thaw cycles) |
Other tests from different labs that may be relevant